Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > MOR MorphoSys > Main Composition
MOR MorphoSys
4.220
+0.010+0.24%
All
YOY
Do not show
Business Unit:EUR
nameYOYOperating income%
Single segment--179.61M100.00%
Region Unit:EUR
nameYOYOperating income%
USA and Canada--156.28M87.01%
Europe and Asia--23.33M12.99%
Company Overview More
MorphoSys AG operates as a commercial-stage biopharmaceutical company. It uses groundbreaking science and technologies to discover, develop, and deliver innovative cancer medicines to patients. The firm also engages in the development and commercialization of therapeutic antibodies for patients suffering from cancer and autoimmune diseases. The company was founded by Andreas Pluckthun and Simon E. Moroney in July 1992 and is headquartered in Planegg, Germany.
CEO: Mr. Jean-Paul Kress
Market: NASDAQ
Listing Date: 04/19/2018
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist